Patents by Inventor Teodor Stelmasiak

Teodor Stelmasiak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10457929
    Abstract: The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analogue or variant thereof) alone or in combination with other suitable enzymes including bromelain, and/or an intestinal extract, as herein described. The present invention also provides methods of using such compositions for the prophylaxis or treatment of a condition arising from gluten intolerance.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: October 29, 2019
    Assignee: Glutagen Pty Ltd.
    Inventors: Teodor Stelmasiak, Hugh James Beatty Cornell
  • Publication number: 20190010477
    Abstract: The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analogue or variant thereof) alone or in combination with other suitable enzymes including bromelain, and/or an intestinal extract, as herein described. The present invention also provides methods of using such compositions for the prophylaxis or treatment of a condition arising from gluten intolerance.
    Type: Application
    Filed: September 24, 2018
    Publication date: January 10, 2019
    Inventors: Teodor Stelmasiak, Hugh James Beatty Cornell
  • Patent number: 10100296
    Abstract: The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analog or variant thereof) alone or in combination with other suitable enzymes including bromelain, and/or an intestinal extract, as herein described. The present invention also provides methods of using such compositions for the prophylaxis or treatment of a condition arising from gluten intolerance.
    Type: Grant
    Filed: January 6, 2010
    Date of Patent: October 16, 2018
    Assignee: Glutagen Pty Ltd
    Inventors: Teodor Stelmasiak, Hugh James Beatty Cornell
  • Publication number: 20120034299
    Abstract: The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analogue or variant thereof) alone or in combination with other suitable enzymes including bromelain, and/or an intestinal extract, as herein described. The present invention also provides methods of using such compositions for the prophylaxis or treatment of a condition arising from gluten intolerance.
    Type: Application
    Filed: January 6, 2010
    Publication date: February 9, 2012
    Applicant: Glutagen Pty Ltd.
    Inventors: Teodor Stelmasiak, Hugh James Beatty Cornell
  • Publication number: 20050191403
    Abstract: Use of one or more peptidase enzymes in the manufacture of a medicament for treatment of gluten intolerance, wherein one or more peptidase enzymes are capable of enzymatic digestion of gluten peptide residues.
    Type: Application
    Filed: November 22, 2004
    Publication date: September 1, 2005
    Inventors: Teodor Stelmasiak, Hugh Cornell